Research - Melbourne, Victoria, Australia
Wintermute Biomedical is a global biopharmaceutical company whose sole focus is to develop next-generation antibiotics in order to address the impending threat of antimicrobial resistance (AMR). Wintermute has developed a truly novel antibiotic compound, which will soon be entering clinical trials. Our vision is to make this antibiotic a reality for the millions of people that fall victim to AMR each year.
Gmail
Varnish
Mobile Friendly
Amazon AWS